Post on 17-Aug-2015
NORIKO MORIOKA | AYAKO MATSUURA | ANJAR DIMARA SAKTI | SUHIMO NAKATSU | SHOHEI HODOTA | TAKU MONJO
Project PresentationSunday, 23 March 2014
Sharon Village
STRATEGY OF EFFICIENT VACCINE DISTRIBUTION IN JAPAN
Global Leader Program for Social Design and Management
Pandemic Influenza
What is influenza?
• occur when a non-human influenza virus gains the ability for efficient and sustained human-to-human transmission and then spreads globally.
INTRODUCTION ABOUT THE VIRUSES
Pandemic
• It is an acute respiratory disorder caused by influenza virus.
• Two types of influenza: Seasonal vs. Pandemic
• Influenza viruses with pandemic potential:
H5N1, H7N9 etc.
What happened on 2009?
A new type of H1N1 virus emerged in April 2009
About 170000 people were infected in Japan by November 2009
No framework about distribution of vaccines before.
Imbalance in demand and supply of vaccine
- The vaccines were not delivered to the right region
- Surplus of the vaccines
http://www.cas.go.jp/jp/seisaku/ful/keikaku/pdf/gl_guideline.pdf
Surveillance and
Information Provision and
Sharing
Prevention Medical System
Maintaining social activityVaccination
OVERVIEW: Guideline for Prevention and Control of Pandemic Influenza In Japan
The Ministry of Health, Labor and Welfare shall deliver vaccines in multiple phases to individual vaccination locations through wholesalers etc., according to the doses requested by each agency and prefectural government.
http://www.cas.go.jp/jp/seisaku/ful/keikaku/pdf/gl_guideline.pdf
Municipality
Prefecture
The Ministry of Health, Labor and Welfare
Request the dose of vaccines
Decide the allocation of vaccines according the amount of request, pandemic situations, demographics in each area
wholesalers
Delivering vaccines
Hospitals & clinics
Strategy for allocation of vaccines
Vaccine Management Business Improvement project (2003)
-Centralized Vaccine Distribution(2008) -Vaccine Tracking System(2013) -National Pediatric Vaccine Stockpile CDC (http://www.cdc.gov/vaccines/programs/vmbip/index.html)
Situation and efforts in U.S.
Centralized Distribution; Deliver Vaccines Directly to Providers
By 2008, CDC had successfully transitioned all 64 awardee health departments from a dispersed model (where they managed their own distribution and 430+ storage depots) to a centralized model (leveraging one private distributor with two national depots) to deliver vaccines directly to providers. The benefits of this change include reduced inventory costs, distribution contract savings, and decreased vaccine wastage.
Vaccine Distribution Contract Between CDC and McKesson Specialty, Inc.
Improve CDC’s Financial Control of National Vaccine Distribution Costs, Reduce High Vaccine Waste and Save money
Centralized Vaccine Distribution
a secure, web-based information technology system that integrates the entire publicly-funded vaccine supply chain from purchasing and ordering through distribution to participating state, local, and territorial health departments (referred to as 'awardees') and health care providers.
VTrckS was launched at four pilot awardee sites in December 2010; the phased roll-out of the system to all 64 awardees was completed in May 2013.
Vaccine Tracking System
VTrckS
VOFA
VACMAN
NIPVAC
Benefits; Not only easy to track, make it much faster, cheaperBut also can easily accumulate and centralize data
Vaccine Tracking System
OBJECTIVE
To develop a Integrated system to help decision makers to provide accurate information about the Multiple Scenario Services and Pre-analysis about distribution of vaccine.
IMPROVING OF JAPAN HEALTH POLICY
Assumed circumstancesPandemic of highly pathogenic influenza virus in Japan
ACTINGDECISION MAKINGINTEGRATED SYSTEM
Application Development
Collaboration with other
perspectives
Management of Health
Epidemiological Studies
Health Policy
Information Technology
Geospatial System
HEALTH INFORMATION DATA CENTER POSITION IN THE USER INTERACTION WITH STAKEHOLDER
VACCINE DISTRIBUTION MANAGEMENTMULTI LAYER MODEL
Distribution of Vaccine
Pandemic Prediction
Demography
Hospital & Health Center
Surveillance (patient)
CENTERRALIZATION NIID
VACCINE COMPANY
LOCAL GOVERNMENT- Location of Hospital, school
- Population
HOSPITAL AGENCY
MHLW
HEALTH CENTER
Implementation System in HealthManagement
Prediction
Vaccine distribution
Demographic
Public facilities
Surveillance
Multi Layer Model
Transportation
Parameter :
Infected Point
Pandemic Population
Transportation Network
Location of Public Facilities
Recommended area to distribute vaccine
GEOSPATIAL ACTIVITIES
APPLICATION OF GIS TO IDENTIFY PANDEMIC AREA DISTRIBUTION
PLANNINGMAPPING
ANALYZINGGEO-DATABASE
VISUALIZING
GEOSPATIAL ACTIVITIES
GEO-MONITORING
STAKEHOLDER -The system would affect the interest of some actors
The supplier of information from surveillance Hospitals Health Center Manufacture Wholesale NIID(National Institute of Infectious Diseases, Japan)
←could need initial investment, but the burden is not highly different from the usual surveillance The receiver of information; need to organize Ministry of Health Labor and Welfare NIID
←fairly ameliorated by the scandalized format and cloud computing
Centralized Information ⇒ Vulnerability
Personal Information ProtectionSide Effect
Quality assurance (When Needed)
For implementation